alexa Abstract | Extended spectrum β-lactamase in clinical isolates of Escherichia coli in a tertiary care centre

Archives of Clinical Microbiology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Background: The Extended Spectrum β-Lactamase (ESBL) producing organisms are increasing rapidly and becoming a major problem in the area of infectious disease. The present study was conducted to know the prevalence of ESBL producing Escherichia coli (E. coli ) isolated from different clinical specimens received in the Department of Microbiology at the Sheri-Kashmir institute of medical sciences, (SKIMS) and to observe the drugresistance pattern of these ESBL producing E. coli.

Methods: Various isolates of E. coli were obtained from patients admitted or attending Out Pateint Department (OPD) over a period of 2 years from 1st August 2005 to 31st July 2007. In this study, 221 E. coli were subjected to screening by using cefotaxime, ceftazidime and ceftriaxone 30mg discs.Among them, 211 were positive for potential ESBL production which were further subjected to confirmatory tests by the following Phenotypic methods;doubledisc synergy test (DDST), phenotypic confirmatory disc diffusion test (PCDDT) and E-test.

Findings: 55.9 % (118/211) of E.coli isolates were positive for ESBL production from different clinical specimen, highest number being from urine (72.9 %). The highest number of ESBL production were from inpatients (71.2 %) followed by outpatient (28.8 %).The resistance pattern of ESBL positive isolates showed higher resistance to 3rd and 4th generation cephalosporins (97.5 % to 99.2 %), quinolones (93.1 % to100 %) and aminoglycosides (65.2 %). They showed high degree of sensitivity to imipenem (98.3 %), nitrofurantoin (91.5 %), gatifloxacin (64.1 %) and amikacin (78.2 %).

Conclusions: The high prevalence of ESBL production among E. coli was observed which should alert the physician as it is associated with indiscriminate use of 3rd and 4th generation cephalosporins. The presence of ESBL in outpatient is of main concern as it can be responsible for communityacquired ESBL and can spread fast in our community. The multidrug resistance pattern of ESBL isolates was observed.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Kaiser Ahmed Manzoor Thakur Bashir Fomda Fomda Gulnaz Bashir Peer Maroof SM Kadri


Ebola Virus Disease, Rotavirus Infection

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version